ZDHHC7 catalyzes S-palmitoylation, transferring palmitate groups to cysteine residues on target proteins. Key findings include:
Substrate Specificity: Directly palmitoylates NLRP3 at Cys126, promoting inflammasome assembly and ASC oligomerization .
Subcellular Localization: Mediates NLRP3 trafficking to the trans-Golgi network (TGN) in resting macrophages and dispersed TGN during activation .
Knockout Models: Zdhhc7-null macrophages show reduced NLRP3 activation and IL-1β secretion .
Therapeutic Potential: Targeting ZDHHC7 suppresses NLRP3-driven inflammation in murine peritonitis models .
Substrate Mapping: Engineered ZDHHC7 mutants paired with "bumped" lipid probes enable proteome-wide identification of S-acylated proteins .
Storage: Lyophilized powder stable at -80°C; reconstitute in Tris/PBS buffer with 6% trehalose .
Activity Assays: Validated via fluorescence resonance energy transfer (FRET) and co-immunoprecipitation (co-IP) .
ZDHHC7 is a member of the DHHC domain-containing protein family that functions as a palmitoyltransferase enzyme. Its primary role is catalyzing the addition of palmitate, a 16-carbon fatty acid, to specific cysteine residues in target proteins through a thioester bond (S-palmitoylation). This post-translational modification is critical for regulating protein localization, stability, and function.
ZDHHC7 is expressed in various tissues and cell types, with notable expression patterns in prostate epithelial cells. Studies have demonstrated that ZDHHC7 expression is frequently decreased in cancer cell lines compared to normal epithelial cells, suggesting potential tumor suppressor functions .
ZDHHC7 has several confirmed substrates involved in cellular polarity and signaling:
Researchers have established that ZDHHC7-mediated palmitoylation of Scribble is particularly critical for maintaining proper cellular polarity. When ZDHHC7 expression is lost or reduced, Scribble palmitoylation decreases, leading to its mislocalization from cell membranes .
Several complementary approaches can be employed to detect ZDHHC7-mediated palmitoylation:
Acyl-Biotin Exchange (ABE) Assay: This method allows for the detection of palmitoylated proteins by replacing palmitate groups with biotin, followed by pull-down with streptavidin and western blotting.
Metabolic Labeling: Cells are treated with alkyne or azide-modified palmitate analogs that can be conjugated to reporter molecules via click chemistry.
Palmitoylation-specific Antibodies: For detection of specific palmitoylated proteins when available.
Confocal Microscopy: To visualize the localization of potential substrates like Scribble, which demonstrates membrane localization when properly palmitoylated .
Researchers commonly validate palmitoylation by expressing wild-type proteins alongside palmitoylation-deficient mutants (e.g., SCRIB C4/10S mutant) in cell lines to compare cellular localization and function .
Producing functional recombinant ZDHHC7 requires careful attention to its transmembrane domain structure:
Expression System Selection: Mammalian expression systems (HEK293 cells) are preferred over bacterial systems to ensure proper folding and post-translational modifications.
Vector Design: Incorporate appropriate tags (His, FLAG, or GST) at the N-terminus to avoid disrupting the catalytic DHHC domain.
Solubilization Strategy: Use mild detergents (DDM or CHAPS) during membrane protein extraction to maintain enzymatic activity.
Activity Verification: Confirm enzyme activity through in vitro palmitoylation assays using known substrates like Scribble.
Storage Considerations: Store with glycerol at -80°C with protease inhibitors to maintain stability and enzymatic activity.